Israel’s Scopio Labs (see here previously) has now received the fourth FDA clearance for its groundbreaking, full-field digital hematology imaging platform. The new Decision Support System significantly helps labs analyze blood smears for anomalies.
4th FDA clearance for AI blood analysis
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.